Inclusion body myositis, a review

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 11, 1996, Pages 1105-1114

  Carpenter, Stirling ^a,b  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL INCLUSION; ELECTRON MICROSCOPY; HISTOPATHOLOGY; HUMAN; MUSCLE BIOPSY; MYOSITIS; PRIORITY JOURNAL; REVIEW;

EID: 0029852686     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199611000-00001     Document Type: Review

References (60)

1. Chou S-M. Myxovirus-like structures in a case of human chronic polymyositis. Science 1967;158:1453-55
2. Chou S-M. Myxovirus-like structures and accompanying nuclear changes in chronic polymyositis. Arch Pathol Lab Med 1968;649-58
3. Sato T, Walker DL, Peters HA, Reese HH, Chou S-M. Chronic polymyositis and myxovirus-like inclusions: Electron microscopic and viral studies. Arch Neurol 1971;24:409-18
4. Carpenter S, Karpati G, Wolfe L. Virus-like filaments and phospholipid accumulation in skeletal muscle: Study of a histochemically distinct chronic myopathy. Neurology 1970;20:889-903
5. Yunis EJ, Samaha FJ. Inclusion body myositis. Lab Invest 1971;25: 240-48
6. Chou, SM. Prospects of viral etiology in polymyositis. In: Kakulas BA, ed. Clinical studies in myology. Amsterdam: Excerpta Medica, 1972:17-28
7. Carpenter S, Karpati G, Heller I, Eisen A. Inclusion body myositis: A distinct variety of idiopathic inflammatory myopathy. Neurology 1978;28:8-17
8. Mikol J, Felten-Papaiconomou A, Ferchal F, et al. Inclusion-body myositis: Clinicopathological studies and isolation of an adenovirus type 2 from muscle biopsy specimen. Ann Neurol 1982;11:576-81
9. Chou SM. Inclusion body myositis: A possible chronic persistent muscle infection by mumps virus. Cleveland Clinic Quarterly 1985;52:583-89
10. Chou SM. Inclusion body myositis: A chronic persistent mumps myositis? Hum Pathol 1986;17:765-76
11. Nishino H, Engel AG, Rima BK. Inclusion body myositis: The mumps hypothesis. Ann Neurol 1989;25:260-64
12. Kallajoki M, Hyypiä T, Halonen P, Örvell C, Rima B, Kalimo H. Inclusion body myositis and paramyxoviruses. Hum Pathol 1991;22:29-32
13. Eisen A, Berry K, Gibson G. Inclusion body myositis (IBM): Myopathy or neuropathy? Neurology 1983;33:1109-14
14. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. IV: Cell-mediated cytotoxicity and muscle fiber necrosis. Ann Neurol 1988;23:225-31
15. Arahata K, Engel AG. Mononuclear antibody analysis of mononuclear cells in myopathies. V: Identification and quantitation of T8+ cytotoxic and T8+ surpressor cells. Ann Neurol 1988;23:493-99
16. Arahata K, Engel AG. Mononuclear antibody analysis of mononuclear cells in myopathies. III: Immunoelectron microscopy aspects of cell-mediated muscle fiber injury. Ann Neurol 1986;19: 112-25
17. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 1984;16:193-208
18. Ringel SP, Kenny CE, Neville HE, Giorno R, Carry MR. Spectrum of inclusion body myositis. Arch Neurol 1987;44:1154-57
19. Lotz BP, Engel AG, Nishino H, Stevens JC, Litchy WJ. Inclusion body myositis: Observations in 40 patients. Brain 1989;112:727-47
20. Beyenburg S, Zierz S, Jerusalem F Inclusion body myositis: Clinical and histopathological features of 36 patients. Clinical Investigator 1993;71:351-61
21. Mendell JR, Sahenk Z, Gales T, Paul L. Amyloid filaments in inclusion body myositis: Novel findings provide insight into nature of filaments. Arch Neurol 1991;48:1229-34
22. Askanas V, Engel WK, Alvarez RB. Enhanced detection of Congored-positive amyloid deposits in muscle fibers of inclusion body myositis and brain of Alzheimer's disease using fluorescence technique. Neurology 1993;43:1265-67
23. De Bleeker JL, Engel AG, Ertl BB. Myofibrillar myopathy with abnormal foci of desmin positivity: II. Immunocytochemical analysis reveals accumulation of multiple other proteins. J Neuropathol Exp Neurol 1996;55:563-77
24. Birgit E, De Bleecker JL, Engel AG. Similarities and differences between target formations (TF) and the lesions in desmin storage myopathy (DSM). Neurology 1994;44(suppl 2):A197
25. Cohen MR, Sulaimen AR, Garancis JC, Wortman RL. Clinical heterogeneity and treatment response in inclusion body myositis. Arthritis & Rheumatism 1989;32:734-40
26. Verma A, Bradley WG, Soule NW, et al. Quantitative morphometric study of muscle in inclusion body myositis. J Neurol Sci 1992;112: 192-98
27. Oldfors A, Larsson NG, Lindberg C, Holme E. Mitochondrial DNA deletions in inclusion body myositis. Brain 1993;116:325-36
28. Karpati G, Pouliot Y, Carpenter S. Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol 1988;23:64-72
29. Griggs RC, Askanas V, DiMauro S, et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705-13
30. Welsh RA, Meyer AT. Nuclear fragmentations and associated fibrils in giant cell tumor of bone. Lab Invest 1970;22:63-72
31. Abe S, Ohno T, Park P, Higaki S, Unno K, Tateushi A. Viral behavior of paracrystalline inclusions in osteoclasts of Paget's disease of bone. Ultrastruct Pathol 1995;19:455-61
32. Chad D, Good P, Bradley WG, Mills J. Inclusion body myositis associated with Sjögren's syndrome. Arch Neurol 1982;39:186-88
33. Gutmann L, Govindan S, Riggs JE, Schochet SS Jr. Inclusion body myositis and Sjögren's syndrome. Arch Neurol 1985;42:1021-22
34. Salama J, Tome FMS, Lebon P, Marie L, Delaporte P, Fardeau M. Myosite à inclusions: Etude clinique, morphologique et virologique concernant une nouvelle observation associée à une sclérodermie généralisée et à un syndrome de Klinefelter. Rev Neurol 1980;136: 863-78
35. Lane RJM, Fulthorpe JJ, Hudgson P. Inclusion body myositis: A case with associated collagen vascular disease responding to treatment. J Neurol Neurosurg Psychiatr 1985;48:270-73
36. Riggs JE, Schochet SS Jr, Gutmann L, McComas CF, Rogers JS II. Inclusion body myositis and chronic immune thrombocytopenia. Arch Neurol 1984;41:93-95
37. Murakami N, Ihara Y, Nonaka I. Muscle fiber degeneration in distal myopathy with rimmed vacuole formation. Acta Neuropathol 1995;89: 29-34
38. Tomé FMS, Fardeau M. Ocular myopathies. Path Res Pract 1985;180: 19-27
39. Argov Z, Yarom R. "Rimmed vacuole myopathy" sparing the quadriceps: A unique disorder in Iranian Jews. J Neurol Sci 1984;64: 33-43
40. Massa R, Weller B, Karpati G, Shoubridge E, Carpenter S. Familial inclusion body myositis among Kurdish-Iranian Jews. Arch Neurol 1991;48:519-22
41. Cole AJ, Kuzniecky R, Karpati G, Carpenter S, Andermann E, Andermann F. Familial myopathy with changes resembling inclusion body myositis and periventricular leucoencephalopathy: A new syndrome. Brain 1988;111:1025-37
42. Figarella-Branger D, Pellissier JF, Pouget J, et al. Myosites à inclusions et maladies neuromusculaires avec vacuoles bordées. Rev Neurol 1992;148:281-90
43. Askanas V, Serdaroglu P, Engel WK, Alvarez RB. Immunolocalization of ubiquitin in muscle biopsies of patients with inclusion body myositis and oculopharyngeal muscular dystrophy. Neurosci Let 1991;130:73-76
44. Askanas V, Engel WK. New advances in inclusion body myositis. Curr Opin Rheumatol 1993;5:732-41
45. Askanas V, Engel WK, Alvarez RB. Light and electron microscopic localization of β-amyloid protein in muscle biopsies of patients with inclusion-body myositis. Am J Pathol 1992;141:31-36
46. Askanas V, Alvarez RB, Engel WK. β-amyloid precursor epitopes in muscle fibers of inclusion body myositis. Ann Neurol 1993;34: 551-60
47. Sarkozi E, Askanas V, Johnson SA, Engel WK, Alvarez RB. β-amyloid precursor protein mRNA is increased in inclusion-body myositis muscle. NeuroReport 1993;4:815-18
48. Askanas V, Engel WK, Alvarez RB. Strong immunoreactivity of β-amyloid precursor protein, including the β-amyloid protein sequences, at human neuromuscular junctions. Neurosci Let 1992;143:96-100
49. Serdaroglu P, Askanas V, Engel WK. Immunocytochemical localization of ubiquitin at human neuromuscular junctions. Neuropathology & Applied Neurobiology 1992;18:232-36
50. Bilak M, Askanas V, Engel WK. Strong immunoreactivity of α1-antichymotrypsin co-localizes with β-amyloid protein and ubiquitin in vacuolated muscle fibers of inclusion-body myositis. Acta Neuropath (Berl) 1993;85:378-82
51. Askanas V, Mirabella M, Engel WK, Alvarez RB, Weisgraber KH. Apolipoprotein E immunoreactive deposits in inclusion-body muscle diseases. Lancet 1994;343:364-65
52. Askanas V, Bilak M, Engel WK, Alvarez RB, Tome F, Leclerc A. Prion protein is abnormally accumulated in inclusion-body myositis. NeuroReport 1993;5:25-28
53. Sarkozi E, Askanas V, Engel WK. Abnormal accumulation of prion protein mRNA in muscle fibers of patients with sporadic inclusion-body myositis and hereditary inclusion-body myopathy. Am J Pathol 1994;145:1280-84
54. Mirabella M, Alvarez RB, Bilak M, Engel WK, Askanas V. Difference of expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myositis. J Neuropathol Exp Neurol 1996;55:774-86
55. Askanas V, Alvarez RB, Mirabella M, Engel WK. Use of antineurofilament antibody to identify paired-helical filaments in inclusion-body myositis. Ann Neurol 1996;39:389-91
56. Tsuzuki K, Fukatsu R, Takamaru Y, et al. Immunohistochemical evidence for amyloid β in rat soleus muscle in chloroquine-induced myopathy. Neurosci Let 1994;182:151-54
57. Zimmermann K, Herget T, Salbaum JM, et al. Localization of the putative precursor of Alzheimer's disease-specific amyloid at nuclear envelopes of adult human muscle. EMBO J 1988;7:367-72
58. Nalbantoglu J, Karpati G, Carpenter S. Conspicuous accumulation of a single-stranded DNA binding protein in skeletal muscle fibers in inclusion body myositis. Am J Pathol 1994;144:874-82
59. Stuurman N, de Jong L, van Driel R. Nuclear frameworks: Concepts and operational definitions. Cell Biol Int Rep 1992;16:837-52
60. Tome FMS, Fardeau M. Nuclear inclusions in oculopharyngeal dystrophy. Acta Neuropath (Berl) 1980;49:85-87